18-MC reduces methamphetamine and nicotine self-administration in rats

Citation
Sd. Glick et al., 18-MC reduces methamphetamine and nicotine self-administration in rats, NEUROREPORT, 11(9), 2000, pp. 2013-2015
Citations number
16
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROREPORT
ISSN journal
09594965 → ACNP
Volume
11
Issue
9
Year of publication
2000
Pages
2013 - 2015
Database
ISI
SICI code
0959-4965(20000626)11:9<2013:1RMANS>2.0.ZU;2-3
Abstract
In previous studies, 18-methoxycoronaridine (18-MC), a novel iboga alkaloid congener, has been found to decrease the intravenous self-administration o f morphine and cocaine in rats. In the present study, 18-MC (1-40 mg/kg, i. p.) dose-dependently decreased the i.v. self-administration of methamphetam ine and nicotine. As in the previous studies, drug self-administration was reduced for greater than or equal to 24 h after the highest dose of 18-MC. A comparison of 18-MC's interactions with all four drugs of abuse studied s o far indicated that 18-MC is least effective in decreasing methamphetamine self-administration and most potent in decreasing nicotine self-administra tion. The results suggest that a nicotinic antagonist action of 18-MC contr ibutes to its putative anti-addictive efficacy. NeuroReport 11:2013-2015 (C ) 2000 Lippincott Williams & Wilkins.